PL2032533T3 - Sposób wytwarzania N-hydroksy-3-[4-[[[(2-metylo-1H-indol-3-ilo)etylo]amino]metylo]fenylo]-2E-2-propenamidu i materiałów wyjściowych do jego otrzymywania - Google Patents

Sposób wytwarzania N-hydroksy-3-[4-[[[(2-metylo-1H-indol-3-ilo)etylo]amino]metylo]fenylo]-2E-2-propenamidu i materiałów wyjściowych do jego otrzymywania

Info

Publication number: PL2032533T3
Authority: PL; Poland
Prior art keywords: methyl; ýýý2; propenamide; indol; hydroxy
Prior art date: 2006-06-12

Application number

PL07784350T

Other languages

English (en)

Inventor

Murat Acemoglu

Joginder S Bajwa

David John Parker

Joel Slade

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-12

Filing date

2007-06-07

Publication date

2013-08-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38832681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2032533(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-06-07 Application filed by Novartis Ag filed Critical Novartis Ag

2013-08-30 Publication of PL2032533T3 publication Critical patent/PL2032533T3/pl

Links

125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title 1
239000007858 starting material Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL07784350T 2006-06-12 2007-06-07 Sposób wytwarzania N-hydroksy-3-[4-[[[(2-metylo-1H-indol-3-ilo)etylo]amino]metylo]fenylo]-2E-2-propenamidu i materiałów wyjściowych do jego otrzymywania PL2032533T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US80452706P	2006-06-12	2006-06-12
US86787806P	2006-11-30	2006-11-30
EP07784350.6A EP2032533B8 (en)	2006-06-12	2007-06-07	Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide and starting materials therefor
PCT/US2007/070564 WO2007146718A2 (en)	2006-06-12	2007-06-07	Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino] methyl]phenyl]-2e-2-propenamide and starting materials therefor

Publications (1)

Publication Number	Publication Date
PL2032533T3 true PL2032533T3 (pl)	2013-08-30

Family

ID=38832681

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07784350T PL2032533T3 (pl)	2006-06-12	2007-06-07	Sposób wytwarzania N-hydroksy-3-[4-[[[(2-metylo-1H-indol-3-ilo)etylo]amino]metylo]fenylo]-2E-2-propenamidu i materiałów wyjściowych do jego otrzymywania

Country Status (31)

Country	Link
US (2)	US20090306405A1 (pl)
EP (2)	EP2032533B8 (pl)
JP (2)	JP5431926B2 (pl)
KR (2)	KR101540194B1 (pl)
CN (4)	CN103086944A (pl)
AR (1)	AR061296A1 (pl)
AU (1)	AU2007257883B2 (pl)
BR (1)	BRPI0712847A2 (pl)
CA (1)	CA2653657C (pl)
CL (2)	CL2007001691A1 (pl)
DK (1)	DK2032533T3 (pl)
EC (1)	ECSP088978A (pl)
ES (2)	ES2416286T3 (pl)
GT (1)	GT200800282A (pl)
HR (1)	HRP20130798T1 (pl)
IL (2)	IL195211A (pl)
IN (1)	IN2015DN00910A (pl)
JO (1)	JO2900B1 (pl)
MA (1)	MA30513B1 (pl)
MX (2)	MX366213B (pl)
MY (1)	MY147576A (pl)
NO (1)	NO341870B1 (pl)
NZ (1)	NZ572707A (pl)
PE (2)	PE20080851A1 (pl)
PL (1)	PL2032533T3 (pl)
PT (1)	PT2032533E (pl)
RU (1)	RU2448090C2 (pl)
TN (1)	TNSN08507A1 (pl)
TW (1)	TWI395734B (pl)
WO (1)	WO2007146718A2 (pl)
ZA (1)	ZA200809490B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT202000004075A1 (it)	2020-02-27	2021-08-27	Flamma Spa	Processo per la preparazione di panobinostat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB146260A (en)	1918-07-11	1921-08-11	Elektro Osmose Ag	A process for preparing proteids charged with immune substances
GB8531612D0 (en) *	1985-12-23	1986-02-05	Beecham Wuelfing Gmbh & Co Kg	Compounds
PE20020354A1 (es) *	2000-09-01	2002-06-12	Novartis Ag	Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
WO2002055742A2 (en)	2001-01-09	2002-07-18	Novartis Ag	Rapid method for screening compounds for in vivo activity
EP1443967B1 (en)	2001-11-06	2007-01-24	Novartis AG	Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
RU2008151724A (ru) *	2006-06-12	2010-07-20	Новартис АГ (CH)	Способ получения солей n-гидрокси-3-[4-[[[2-(2-метил-1н-индол-3-ил)этил]амино]метил]фенил]-2е-2-пропенамида

2007
- 2007-06-07 CN CN2012103501544A patent/CN103086944A/zh active Pending
- 2007-06-07 IN IN910DEN2015 patent/IN2015DN00910A/en unknown
- 2007-06-07 JP JP2009515575A patent/JP5431926B2/ja active Active
- 2007-06-07 CA CA2653657A patent/CA2653657C/en active Active
- 2007-06-07 PL PL07784350T patent/PL2032533T3/pl unknown
- 2007-06-07 US US12/302,572 patent/US20090306405A1/en not_active Abandoned
- 2007-06-07 EP EP07784350.6A patent/EP2032533B8/en active Active
- 2007-06-07 ES ES07784350T patent/ES2416286T3/es active Active
- 2007-06-07 HR HRP20130798TT patent/HRP20130798T1/hr unknown
- 2007-06-07 KR KR1020147026120A patent/KR101540194B1/ko not_active Expired - Fee Related
- 2007-06-07 CN CN2011100630820A patent/CN102174008A/zh active Pending
- 2007-06-07 BR BRPI0712847-9A patent/BRPI0712847A2/pt not_active IP Right Cessation
- 2007-06-07 AU AU2007257883A patent/AU2007257883B2/en not_active Ceased
- 2007-06-07 EP EP11179043.2A patent/EP2394991B1/en active Active
- 2007-06-07 PT PT77843506T patent/PT2032533E/pt unknown
- 2007-06-07 MX MX2012002221A patent/MX366213B/es unknown
- 2007-06-07 ES ES11179043.2T patent/ES2553255T3/es active Active
- 2007-06-07 KR KR20087030232A patent/KR101493530B1/ko not_active Expired - Fee Related
- 2007-06-07 RU RU2008151726/04A patent/RU2448090C2/ru active
- 2007-06-07 NZ NZ572707A patent/NZ572707A/en not_active IP Right Cessation
- 2007-06-07 MX MX2008015898A patent/MX2008015898A/es active IP Right Grant
- 2007-06-07 WO PCT/US2007/070564 patent/WO2007146718A2/en not_active Ceased
- 2007-06-07 CN CN2011100629486A patent/CN102167678B/zh active Active
- 2007-06-07 CN CNA2007800217257A patent/CN101466674A/zh active Pending
- 2007-06-07 DK DK07784350.6T patent/DK2032533T3/da active
- 2007-06-08 PE PE2007000720A patent/PE20080851A1/es active IP Right Grant
- 2007-06-08 PE PE2011002097A patent/PE20120221A1/es active IP Right Grant
- 2007-06-08 AR ARP070102498A patent/AR061296A1/es unknown
- 2007-06-11 CL CL200701691A patent/CL2007001691A1/es unknown
- 2007-06-11 TW TW096120985A patent/TWI395734B/zh not_active IP Right Cessation
- 2007-06-12 JO JO2007219A patent/JO2900B1/en active
2008
- 2008-11-06 ZA ZA200809490A patent/ZA200809490B/xx unknown
- 2008-11-10 IL IL195211A patent/IL195211A/en active IP Right Grant
- 2008-11-28 MY MYPI20084865A patent/MY147576A/en unknown
- 2008-12-05 TN TNP2008000507A patent/TNSN08507A1/en unknown
- 2008-12-10 GT GT200800282A patent/GT200800282A/es unknown
- 2008-12-12 EC EC2008008978A patent/ECSP088978A/es unknown
- 2008-12-12 MA MA31472A patent/MA30513B1/fr unknown
2009
- 2009-01-09 NO NO20090137A patent/NO341870B1/no not_active IP Right Cessation
2010
- 2010-09-13 CL CL2010000973A patent/CL2010000973A1/es unknown
2011
- 2011-09-23 US US13/243,001 patent/US8536346B2/en active Active
2013
- 2013-10-25 JP JP2013222442A patent/JP5809223B2/ja active Active
2014
- 2014-07-28 IL IL233836A patent/IL233836A/en active IP Right Grant

Also Published As

Publication number	Publication date
CN103086944A (zh)	2013-05-08
RU2448090C2 (ru)	2012-04-20
IN2015DN00910A (pl)	2015-07-10
PT2032533E (pt)	2013-06-28
NO20090137L (no)	2009-03-03
RU2008151726A (ru)	2010-07-20
EP2032533B1 (en)	2013-04-03
JP2014058532A (ja)	2014-04-03
CN102174008A (zh)	2011-09-07
CN102167678B (zh)	2013-08-28
GT200800282A (es)	2009-03-09
KR101540194B1 (ko)	2015-07-28
US8536346B2 (en)	2013-09-17
IL195211A0 (en)	2009-08-03
NZ572707A (en)	2011-12-22
KR20090015969A (ko)	2009-02-12
ES2416286T3 (es)	2013-07-31
MX2008015898A (es)	2009-01-12
CL2010000973A1 (es)	2011-07-01
IL233836A (en)	2017-05-29
DK2032533T3 (da)	2013-07-01
HK1162029A1 (en)	2012-08-17
MA30513B1 (fr)	2009-06-01
ECSP088978A (es)	2009-01-30
MY147576A (en)	2012-12-31
AU2007257883B2 (en)	2011-09-29
CA2653657C (en)	2015-10-27
EP2394991A1 (en)	2011-12-14
TNSN08507A1 (en)	2010-04-14
CL2007001691A1 (es)	2008-05-16
HRP20130798T1 (en)	2013-09-30
IL233836A0 (en)	2014-09-30
PE20120221A1 (es)	2012-03-21
TW200815345A (en)	2008-04-01
NO341870B1 (no)	2018-02-12
TWI395734B (zh)	2013-05-11
WO2007146718A2 (en)	2007-12-21
WO2007146718A3 (en)	2008-06-19
HK1126759A1 (en)	2009-09-11
US20120010418A1 (en)	2012-01-12
ZA200809490B (en)	2009-10-28
KR101493530B1 (ko)	2015-02-13
EP2032533B8 (en)	2013-12-11
AU2007257883A1 (en)	2007-12-21
EP2032533A2 (en)	2009-03-11
US20090306405A1 (en)	2009-12-10
CA2653657A1 (en)	2007-12-21
ES2553255T3 (es)	2015-12-07
JP5431926B2 (ja)	2014-03-05
IL195211A (en)	2014-08-31
JP2009540008A (ja)	2009-11-19
AR061296A1 (es)	2008-08-20
JO2900B1 (en)	2015-09-15
KR20140117703A (ko)	2014-10-07
JP5809223B2 (ja)	2015-11-10
MX366213B (es)	2019-07-01
PE20080851A1 (es)	2008-08-18
CN102167678A (zh)	2011-08-31
CN101466674A (zh)	2009-06-24
BRPI0712847A2 (pt)	2012-08-07
EP2394991B1 (en)	2015-09-23

Publication	Publication Date	Title
PL2631241T3 (pl)	2019-02-28	Sposób generowania białka i jego zastosowanie
EP2032925A4 (en)	2014-05-21	THERMAL TREATMENT OF PARTICLE MATERIAL WITH INDIRECT HEAT
SI1999259T1 (sl)	2014-11-28	Usmerjeno vključevanje amino kislin v molekule
ZA200808364B (en)	2010-02-24	2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
IL214832A0 (en)	2011-09-27	4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
IL198120A0 (en)	2011-08-01	Polypeptide ligands for targeting cartilage and methods of use thereof
AU2007274035A8 (en)	2009-02-19	Process for preparing particles of proteinaceous material
IL198117A0 (en)	2009-12-24	Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
EP2120965A4 (en)	2011-05-18	N-HALOGENATED AMINO BINDINGS AND DERIVATIVES
EP2109673A4 (en)	2010-09-08	METHOD AND DEVICE FOR REINFORCED PROTEIN EXPRESSION AND CLEANING
IL193210A0 (en)	2009-02-11	Amino indazole derivatives
IL197979A0 (en)	2009-12-24	Method for peptide synthesis
ZA200900626B (en)	2010-04-28	4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
PL1981598T3 (pl)	2015-10-30	Plastyfikator naturalnego pochodzenia dla lakieru do paznokci
GB0626021D0 (en)	2007-02-07	The stabilisation of proteins
TWI372762B (en)	2012-09-21	Amino derivatives of b-homoandrostanes and b-heteroandrostanes
EP2006302A4 (en)	2011-02-16	PROTEIN COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
PL2032533T3 (pl)	2013-08-30	Sposób wytwarzania N-hydroksy-3-[4-[[[(2-metylo-1H-indol-3-ilo)etylo]amino]metylo]fenylo]-2E-2-propenamidu i materiałów wyjściowych do jego otrzymywania
IL195059A0 (en)	2009-08-03	Process for preparing duloxetine and intermediates thereof
PL2242479T3 (pl)	2012-02-29	Filtracja białek z zastosowaniem przeciwciśnienia
EP2121726A4 (en)	2010-10-20	PROTEIN PARTICLE
GB0605295D0 (en)	2006-04-26	Amino and derivatives
SI2032533T1 (sl)	2013-07-31	Postopek za izdelavo N-hidroksi-3-(4-(((-2-(2-metil-1H-indol-3-il)etil)amino)metil)- afenil)-2E-2-propenamida in izhodni materiali za to
GB0625899D0 (en)	2007-02-07	Apparatus for the cultivation of shellfish
GB0613884D0 (en)	2006-08-23	Particles of proteinaceous material